9-([1,1'-Biphenyl]-4-yl)-10-bromo-2-phenylanthracene>98.0%(HPLC)1g

ROTI®Cell PBS/EDTA

4-Propoxybenzoic Acid>98.0%(GC)(T)25g

(2-Bromophenyl)(pyrrolidin-1-yl)methanone, 95.0%, 1g

N-((6-Chloropyridin-3-yl)methyl)ethanamine, 95.0%, 250mg

Nalpha-Carbobenzoxy-L-histidine>99.0%(T)25g

C-(2,5-Dimethyl-2H-pyrazol-3-yl)-methylamine, 95.0%, 5g

(3R,4R)-2,5-Dioxotetrahydrofuran-3,4-diyl diacetate, 95.0%, 25g

(4R,4'R)-2,2'-methylenebis[4,5-dihydro-4-(1-methylethyl)oxazole], 95%, 5g

Benzyl (imino(1H-pyrazol-1-yl)methyl)carbamate, 95.0%, 10g

tert-Butyl 2,6-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate, 95.0%, 1g

N-(4-methyl-1,3-thiazol-2-yl)piperidine-4-carboxamide hydrochloride, 95.0%, 500mg

Methyl 3-bromo-2,4-dimethylbenzoate, 95.0%, 250mg